We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+15.22%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
+$148M
Cap. Flow
+$27M
Cap. Flow %
2.23%
Top 10 Hldgs %
38.39%
Holding
516
New
39
Increased
143
Reduced
266
Closed
39

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.89M
2
BABA icon
Alibaba
BABA
+$4.05M
3
SLV icon
iShares Silver Trust
SLV
+$4M
4
FUTU icon
Futu Holdings
FUTU
+$3.28M
5
AVGO icon
Broadcom
AVGO
+$3.25M

Top Sells

Rank Stock Value
1
SAP icon
SAP
SAP
+$2.28M
2
TPR icon
Tapestry
TPR
+$2.13M
3
ABT icon
Abbott
ABT
+$2.05M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.05M
5
TMUS icon
T-Mobile US
TMUS
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 39.61%
2 Healthcare 20.82%
3 Communication Services 12.95%
4 Consumer Discretionary 11.61%
5 Consumer Staples 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZLAB icon
301
Zai Lab
ZLAB
$2.86B
$284K 0.02%
8,380
-3,247
-28% -$112K
BCRX icon
302
BioCryst Pharmaceuticals
BCRX
$2.71B
$279K 0.02%
36,796
-5,231
-12% -$43.6K
VCEL icon
303
Vericel Corp
VCEL
$2.29B
$278K 0.02%
8,845
-1,266
-13% -$45.5K
HRMY icon
304
Harmony Biosciences
HRMY
$2.32B
$278K 0.02%
10,085
-1,448
-13% -$49.9K
IRTC icon
305
iRhythm Holdings
IRTC
$4.13B
$275K 0.02%
+1,600
New +$254K
HLT icon
306
Hilton Worldwide
HLT
$72.6B
$265K 0.02%
1,021
– –
ABCL icon
307
AbCellera Biologics
ABCL
$3.18B
$263K 0.02%
52,381
-7,568
-13% -$33.4K
DSGN icon
308
Design Therapeutics
DSGN
$917M
$263K 0.02%
34,982
+23,580
+207% +$118K
HUM icon
309
Humana
HUM
$46.7B
$261K 0.02%
+1,000
New +$263K
AVDL
310
DELISTED
Avadel Pharmaceuticals
AVDL
$260K 0.02%
17,020
-2,410
-12% -$31.4K
GSK icon
311
GSK
GSK
$101B
$259K 0.02%
6,000
+5,662
+1,675% +$221K
JANX icon
312
Janux Therapeutics
JANX
$1.02B
$257K 0.02%
10,534
-1,351
-11% -$32.9K
IMCR icon
313
Immunocore
IMCR
$1.77B
$255K 0.02%
7,021
-961
-12% -$32.6K
AUPH icon
314
Aurinia Pharmaceuticals
AUPH
$2.06B
$255K 0.02%
23,073
-4,062
-15% -$44.4K
NVCR icon
315
NovoCure
NVCR
$2.05B
$253K 0.02%
19,597
-2,794
-12% -$37.3K
ALV icon
316
Autoliv
ALV
$8.85B
$247K 0.02%
2,000
– –
NVAX icon
317
Novavax
NVAX
$1.31B
$247K 0.02%
28,470
-4,061
-12% -$31.6K
TXG icon
318
10x Genomics
TXG
$7.52B
$234K 0.02%
20,055
-2,258
-10% -$29.4K
XPEV icon
319
XPeng
XPEV
$11.2B
$234K 0.02%
10,000
-20,000
-67% -$401K
ARDX icon
320
Ardelyx
ARDX
$1.03B
$233K 0.02%
42,241
-5,812
-12% -$31.6K
SNDX icon
321
Syndax Pharmaceuticals
SNDX
$1.77B
$232K 0.02%
15,099
-2,183
-13% -$28.6K
XERS icon
322
Xeris Biopharma Holdings
XERS
$1.55B
$230K 0.02%
28,305
-3,862
-12% -$25.7K
GLUE icon
323
Monte Rosa Therapeutics
GLUE
$1.36B
$228K 0.02%
30,825
-1,529
-5% -$8.1K
STOK icon
324
Stoke Therapeutics
STOK
$2.13B
$226K 0.02%
9,605
-1,361
-12% -$23.3K
GMAB icon
325
Genmab
GMAB
$19.6B
$225K 0.02%
7,350
-11,071
-60% -$270K
11 12
13
14 15

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q3 2025 Portfolio in Review

As of Q3 2025, China Universal Asset Management Company held 516 positions worth $1.21B, up 14% from $1.06B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company's Q3 2025 filing shows 39 new, 143 increased, 266 reduced and 39 closed positions. Its largest new stake was Alibaba: 30,923 shares worth $5.53M. The largest sale was SAP, an estimated $2.28M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.

  • China Universal Asset Management Company's largest Q3 2025 buy was Alibaba: 30,923 shares worth $5.53M.
  • China Universal Asset Management Company added most to NVIDIA in Q3 2025, an estimated $6.89M increase.
  • China Universal Asset Management Company's biggest Q3 2025 reduction was SAP, cutting an estimated $2.28M.
  • China Universal Asset Management Company fully exited Tapestry in Q3 2025, selling an estimated $2.13M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.21B portfolio in Q3 2025.
  • China Universal Asset Management Company opened 39 new positions and closed 39 in Q3 2025.
  • China Universal Asset Management Company's portfolio value rose 14% quarter-over-quarter to $1.21B.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.